Shaily Engineering Plastics Limited
SHAILY.BO
Bombay Stock Exchange2,798.65
INR
-71.50
- -
Shaily Engineering Plastics Limited
SHAILY.BO
(Bombay Stock Exchange)
Recent
price
2,798.65
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Shaily Engineering Plastics Limited manufactures and sells precision injection-molded plastic components, sub-assemblies, molds, and dies for original equipment manufacturers across healthcare, consumer, industrial, automotive, and packaging sectors; its core offerings include specialty medical devices such as pen injectors, auto-injectors, wearable injectors, inhalers, sprays, pumps, and insulin pens, alongside pharmaceutical packaging for solid and liquid formulations, contract development and manufacturing services; consumer products encompassing kitchen and cooking devices, storage and cleaning items, plastic and plastic-electronic toys, sheet steel furniture like cabinets, drawers, tables, and storage units; industrial components for lighting, appliances, high-performance engineering polymers including the only licensed processing of Torlon in India, automotive parts, razors, and cosmetics casings; secondary operations such as pad printing, hot stamping, painting, ultrasonic welding, vacuum metalizing, and automated assembly processes. The company operates seven manufacturing facilities with over 200 injection molding machines, more than 2,000 employees, and precise high-speed automated and robotic production lines at sites in Savli, Halol, and Rania near Vadodara, Gujarat, India, exporting to approximately 40 countries as India's largest exporter of plastic components and holding certifications including ISO 9001:2015, IATF 16949:2016, ISO 13485:2016, ISO 15378:2017, MDSAP, SA 8000:2014, and FDA 21 CFR 820 compliance. Founded in 1987 by Mike Sanghvi as a startup with two machines and publicly listed on NSE/BSE under ticker SHAILY.BO with headquarters at Survey No. 364/366, Rania, Taluka Savli, Vadodara, Gujarat, the company maintains a diversified platform across healthcare, consumer-home furnishings, FMCG packaging, pharma, automotive, consumer electronics, and industrial segments, serving clients like GE Appliances, Garrett Advancing Motion, Schaeffler, and Fortune 100 brands while utilizing 100% renewable energy and up to 35% recycled materials. Recent developments include strategic partnerships such as a 2023 collaboration with a major automotive OEM for lightweight composite materials projected to add INR 100 crore in revenue over three years, R&D investments at 6% of annual revenue, plans for five new non-automotive products by end-FY2024, commercial launches of teriparatide in UK/USA by early 2025, liraglutide in USA/Europe in H2 2025, semaglutide in multiple markets late 2025-early 2026, and exhibit batches for tirzepatide, alongside expansion via seven patent platforms through its UK subsidiary, a Q1 FY2026 earnings call in August 2025, and significant block deals in 2025 where institutional investors including Abu Dhabi Investment Authority, 360 One Group, Motilal Oswal Mutual Fund, BofA Securities, Societe Generale, Aditya Birla Sun Life Mutual Fund acquired a 2.9% stake for INR 284 crore from Lighthouse Funds, followed by promoter stake sales to Morgan Stanley.